Drug Details
Therapeutic Class:
Topical immune response modifier
Forms:
Cream
Administration:
Topical application to affected area
Therapeutic Uses:
- Actinic keratoses on the face and scalp
- Superficial basal cell carcinoma on the neck, trunk, and limbs
- External warts in the genital and anal areas
Controlled Status:
Not a controlled substance
Imiquimod (Zyclara) Drug Class
Imiquimod (i-mi-kwi-mod) is an immune response modifier.
Imiquimod (Zyclara) Age Range
Imiquimod is approved for use in adults for treatment of actinic keratoses and superficial basal cell carcinoma. It is approved for use in adults and children 12 years and older for genital or anal warts.
SOCIAL